Celgene CorpAdd to My Watchlist

CELG:USNASDAQ GSIndustry: Medical-Biomedical/Gene
  • 141.86
  • 2.02  1.44%
    Today's Change
  • 139.84
    Previous Close
  • Today
    52 Week Low - High
8:10 pm ET 4/16/2014
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding406 million
Market Cap$58 billion
Return on Equity ttm25.70%
Last DividendCELG:US does not pay a dividend
EPS: Year Actual ttm4.680
EPS: Year Est. 12/14 ttm7.211
EPS: Quarterly Actual 12/13 1.51
EPS: Quarterly Est. 3/14 1.65
Price/Earnings ttm30.31
Relative Price/Earnings1.764
Earnings Growth Rate3.55
Company Description
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
Revenue$6 billion
Net Income$1 billion
Total Assets$13 billion
Web Sitewww.celgene.com

Latest Headlines


Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

Sign In Now


Not Registered?

Get complete access to The Washington Post online - it's FREE!